Breaking Breast Imaging News Alert: The U.S. Preventive Services Task Force (USPSTF) has updated its breast cancer screening guidelines. Now, women at average risk are advised to begin biennial mammography screenings at age 40, instead of the previous starting age of 50. However, an accompanying editorial in JAMA Oncology, Wendie Berg, MD, PhD, of the University of Pittsburgh School of Medicine, pointed out that USPSTF guidelines do not apply to women at high risk for breast cancer, and noted that regular risk assessment should commence at age 25 years to identify the high-risk who should start annual MRI screening. https://lnkd.in/eEmu4BNu
CancerIQ’s Post
More Relevant Posts
-
I'm really encouraged by the updated USPSTF guidelines recommending biennial mammograms starting at age 40. This change is not just about policy—it's a pivotal shift towards early detection that all healthcare providers can rally behind. Dr. Wendie Berg’s emphasis for starting risk assessments at age 25 to identify those at high risk aligns with our mission at CancerIQ to personalize prevention. This proactive approach is vital, underscoring the essential role healthcare providers play in adapting their practices to meet evolving guidelines. #BreastCancerAwareness #GeneticCounseling #CancerIQ #CancerPrevention #CancerRisk
Breaking Breast Imaging News Alert: The U.S. Preventive Services Task Force (USPSTF) has updated its breast cancer screening guidelines. Now, women at average risk are advised to begin biennial mammography screenings at age 40, instead of the previous starting age of 50. However, an accompanying editorial in JAMA Oncology, Wendie Berg, MD, PhD, of the University of Pittsburgh School of Medicine, pointed out that USPSTF guidelines do not apply to women at high risk for breast cancer, and noted that regular risk assessment should commence at age 25 years to identify the high-risk who should start annual MRI screening. https://lnkd.in/eEmu4BNu
USPSTF Finalizes New Breast Cancer Screening Recommendations
medpagetoday.com
-
The landscape of breast cancer screening is evolving. According to the latest update from the US Preventive Services Task Force, the recommended screening age for breast cancer has been revised from age 50 to age 40 for the average risk patient. Stay informed about these crucial changes and their impact on early detection efforts. Check out this article for more details on the latest advancements in breast cancer research and how they intersect with screening guidelines: https://lnkd.in/eEmu4BNu
USPSTF Finalizes New Breast Cancer Screening Recommendations
medpagetoday.com
-
1. Women who breastfeed after breast cancer treatment do not face a higher risk of cancer recurrence or new tumors, even those with the BRCA mutation. 2. A new combination of immunotherapy and chemotherapy has shown promising results in a phase two trial for metastatic non-small cell lung cancer, improving tumor shrinkage rates. 3. An exceptional outcome was reported for a rare pregnancy-related cancer, where a treatment combination led to a 96% eradication rate of the cancer. 4. An advanced AI algorithm, trained on over a billion tumor images, has the potential to detect molecular anomalies that may not be visible to the human eye, aiding personalized medicine. 5. Combining immunotherapy with radiation therapy before surgery enhances survival rates and may allow for the preservation of affected organs in various cancers. 6. Research showed encouraging results for rectal preservation in cancer patients, suggesting that surgery could potentially be avoided in the future. 7. These innovative treatment combinations may also be applicable to other cancers, such as those affecting the ear, nose, throat, and lungs.
From new treatments to AI: advances in the fight against cancer — Canadian Affairs
apple.news
-
The below article talks about the benefits and disadvantages of breast cancer screening with abbreviated MRI. It finds 11.8 tumors whereas 3-D tomosynthesis finds 4.8 tumors. Abbreviated MRI appears to be the gold standard for finding breast cancer early. The downside is that there will be more false positives and more unnecessary biopsies. But that usually doesn’t result in death, unlike untimely breast cancer diagnosis. #breastcancerscreening #breastcancer
What’s the best way to screen dense breasts?
fredhutch.org
-
Bio-Rad's ddPCR technology being promoted in the incredible work done by Dr Simon Vincent, Isaac Garcia-Murillas and co. in the following BBC article 'New blood test 'can predict' breast cancer return' https://lnkd.in/e7feqJ3Z Give it a read and see how ddPCR is being utilized to aid ground breaking science!
I spy with my little eye Bio-Rad's ddPCR technology being promoted in the incredible work done by Dr Simon Vincent, Dr Isaac Garcia-Murillas and co. in the following BBC article 'New blood test 'can predict' breast cancer return' https://lnkd.in/e7feqJ3Z Give it a read and see how ddPCR is being utilized to aid ground breaking science!
Breast cancer: New blood test can predict return, researchers say
bbc.co.uk
-
presented my research work in cancercon tittle: Locally Advanced Breast Cancer in Pakistani Women: Clinical Features and Prognostic Factors https://lnkd.in/dRFkn6jf
Locally Advanced Breast Cancer in Pakistani Women: Clinical Features and Prognostic Factors
thejas.com.pk
-
Receiving a false-positive result on a mammogram may discourage some women from returning for routine breast cancer screenings in the future, according to NIH-funded research at the UC Davis Comprehensive Cancer Center at UC Davis Health. An analysis of more than 3.5 million mammograms found that only 61% of women who had a false-positive finding requiring another mammogram to confirm the results returned for subsequent screening. The research highlights the need for better education about false-positive results and the importance of continued breast cancer screening. Read more: https://lnkd.in/ejAyNd4a #CancerPrevention #NIH #CancerResearch #Mammogram
False-positive mammogram results discourage some women from future screenings
health.ucdavis.edu
-
Thanks to all donors to Dutch Cancer Society KWF Kankerbestrijding NKI researcher Marleen Kok and her team received 4.1 million euros for large-scale international research into forgoing chemotherapy in women with early-stage triple-negative breast cancer. The study will investigate whether we can safely forgo chemotherapy in women with many immune cells around their tumors, as this indicates an excellent prognosis. Marleen received this amazing cheque from Dorine Manson, head of the Dutch Cancer Society. Dorine: "This research closely aligns with our own goals: better treatments and better quality of life for patients during and after their treatment. We will follow this research with great interest." In this new trial, patients can decide whether they want to receive chemotherapy after surgery in collaboration with their physician. The researchers will follow 490 women and will measure their quality of life through questionnaires. The study will show whether immune cells are a reliable indicator when deciding whether to provide chemotherapy. Read more ➡️ https://lnkd.in/gXPS3gJu #research #funding #cancerresearch #breastcancer #trial
Forgoing chemotherapy for stage 1 breast cancer: 4 million euros for large-scale international study | Netherlands Cancer Institute
nki.nl
-
See what your peers are publishing: Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma 🔬 Battling tough tumors like pancreatic ductal adenocarcinoma (PDA) and triple-negative breast cancer (TNBC) remains a challenge despite progress in cancer therapy. Surgical removal is often the first line, but the risk of leaving behind residual tumor cells is high, leading to poorer outcomes. 💡 Could a breakthrough be on the horizon? Explore the potential of CAR T cell therapy for local, intraoperative use. These innovative treatments have shown promise in other cancers, offering hope for safer, more effective adjuvant therapies. 👩⚕️ Research aims to provide promising methods to improve the clearance of residual tumor cells post-surgery, potentially leading to better clinical outcomes for patients with certain types of cancer. Find out how Live-Cell Imaging and Analysis is helping in cancer treatment: https://ow.ly/Yjqx50QJetQ #Research #CancerTherapy #Oncology #LiveCellAnalysis
-
-
See what your peers are publishing: Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma 🔬 Battling tough tumors like pancreatic ductal adenocarcinoma (PDA) and triple-negative breast cancer (TNBC) remains a challenge despite progress in cancer therapy. Surgical removal is often the first line, but the risk of leaving behind residual tumor cells is high, leading to poorer outcomes. 💡 Could a breakthrough be on the horizon? Explore the potential of CAR T cell therapy for local, intraoperative use. These innovative treatments have shown promise in other cancers, offering hope for safer, more effective adjuvant therapies. 👩⚕️ Research aims to provide promising methods to improve the clearance of residual tumor cells post-surgery, potentially leading to better clinical outcomes for patients with certain types of cancer. Find out how Live-Cell Imaging and Analysis is helping in cancer treatment: https://ow.ly/Yjqx50QJetQ #Research #CancerTherapy #Oncology #LiveCellAnalysis
-
Eco-Conscious Engineer | Owner and Research Director | Building Safe Manufacturing & Sustainable Products at Herbalix Restoratives
5moNow the change to Biennial mammography, tells us that there are inherited risks that should be explained to the patients. Is the individual absorbing x amount of radiation? and is this metered for the person’s record? Why is it so difficult to offer alternative such as thermography to observe if asymmetry is present. Here’s a question, if the breast lymphatic system is a opened system versus blood’s closed system, than the breast cellular waste is escaping via the axilla. With thermography one can analyze if between the breast and axilla there exists a restriction(s), not so with a mammogram and the . Filter .5,1.0,1.5 focus is solely on the breast so not to damage other organs. One other point, if the breast tissue has accumulated a mixture of heavy metal contaminants the mammograms reflect off the metal salts trapped in the breast tissue, similar to shining a flashlight onto a mirror.